Unraveling the Interaction of Aspirin, Ticagrelor, and Rosuvastatin on the Progression of Atherosclerosis and Inflammation in Diabetic Mice

被引:13
|
作者
Ye, Yumei [1 ]
Nylander, Sven [2 ]
Birnbaum, Yochai [3 ]
机构
[1] Univ Texas Med Branch, Dept Biochem & Mol Biol, 301 Univ Blvd, Galveston, TX 77555 USA
[2] AstraZeneca R&D, Molndal, Sweden
[3] Baylor Coll Med, Dept Med, Cardiol Sect, Houston, TX 77030 USA
关键词
Aspirin; Statin; Ticagrelor; Clopidogrel; Adenosine; Atherosclerosis; Inflammation; ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE SYNTHASE; LOW-DOSE ASPIRIN; RECEPTOR-DEFICIENT MICE; CYTOKINE-CHEMOKINE AXIS; MYOCARDIAL-INFARCTION; INDUCED CARDIOPROTECTION; NEUTROPHIL RESPONSES; ANTIPLATELET THERAPY; 15-EPI-LIPOXIN A(4);
D O I
10.1007/s10557-017-6763-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We explored the effects of rosuvastatin, aspirin, ticagrelor, and clopidogrel, alone or in combinations on the progression of atherosclerosis and inflammasome activation in diabetic mice. Statins and ticagrelor increase the production of 15-epi-lipoxin A(4) via cyclooxygenase-2. Aspirin alone increases 15-epi-lipoxin A(4), but when combined with statins, cyclooxygenase-2 is completely blocked. ApoE(-/-)/db(+)/db(+) double-knockout mice received rosuvastatin (5 mg/kg/day), aspirin (25 mg/kg/day), ticagrelor (300 mg/kg/day), clopidogrel (75 mg/kg/day), or their combination for 14 weeks. Serum 15-epi-lipoxin A(4) levels and aortic wall cholesterol content, IL-1 beta, IL-6, and TNF-alpha levels, and plaque area were assessed. Aspirin, ticagrelor, and rosuvastatin increased 15-epi-lipoxin A(4) levels. The combination of rosuvastatin + ticagrelor provided an additive effect. Aspirin attenuated the effect of both ticagrelor and rosuvastatin. Aspirin, ticagrelor, and rosuvastatin reduced the area of the atherosclerotic plaque. The combination of ticagrelor + rosuvastatin provided additive effects. There was a negative interaction when aspirin was combined with ticagrelor or rosuvastatin. Aspirin, ticagrelor, and rosuvastatin decreased serum IL-1 beta and IL-6 levels. There was no interaction between aspirin and ticagrelor or aspirin and rosuvastatin, whereas combining rosuvastatin and ticagrelor provided an additive effect. Aspirin, ticagrelor, and rosuvastatin all decreased TNF-alpha levels. Aspirin attenuated the effect of both ticagrelor and rosuvastatin, and there was no additive effect of combining ticagrelor + rosuvastatin. We found an intricate interaction between aspirin, ticagrelor, and rosuvastatin, as aspirin reduced both ticagrelor and rosuvastatin ability to ameliorate inflammation and atherosclerosis. In contrast, we found additive effects when ticagrelor and rosuvastatin were combined.
引用
收藏
页码:489 / 500
页数:12
相关论文
共 50 条
  • [41] Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice
    Lim, A. K. H.
    Ma, F. Y.
    Nikolic-Paterson, D. J.
    Thomas, M. C.
    Hurst, L. A.
    Tesch, G. H.
    DIABETOLOGIA, 2009, 52 (08) : 1669 - 1679
  • [42] Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice
    A. K. H. Lim
    F. Y. Ma
    D. J. Nikolic-Paterson
    M. C. Thomas
    L. A. Hurst
    G. H. Tesch
    Diabetologia, 2009, 52 : 1669 - 1679
  • [43] Platelet-neutrophil interaction aggravates vascular inflammation and promotes the progression of atherosclerosis by activating the TLR4/NF-κB pathway
    Liang, Xiao
    Xiu, Chunhong
    Liu, Minghao
    Lin, Chaolan
    Chen, Hanchen
    Bao, Rui
    Yang, Shusen
    Yu, Jiangbo
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (04) : 5612 - 5619
  • [44] Role of Combination Treatment of Aspirin and Zinc in DMH-DSS-induced Colon Inflammation, Oxidative Stress and Tumour Progression in Male BALB/c Mice
    Babu, Singothu Siva Nagendra
    Singla, Shivani
    Jena, Gopabandhu
    BIOLOGICAL TRACE ELEMENT RESEARCH, 2023, 201 (03) : 1327 - 1343
  • [45] Role of Combination Treatment of Aspirin and Zinc in DMH-DSS-induced Colon Inflammation, Oxidative Stress and Tumour Progression in Male BALB/c Mice
    Singothu Siva Nagendra Babu
    Shivani Singla
    Gopabandhu Jena
    Biological Trace Element Research, 2023, 201 : 1327 - 1343
  • [46] Inhibition of inflammation by pentosan polysulfate impedes the development and progression of severe diabetic nephropathy in aging C57B6 mice
    Wu, Jin
    Guan, Tian-jun
    Zheng, Shirong
    Grosjean, Fabrizio
    Liu, Weicheng
    Xiong, Huabao
    Gordon, Ronald
    Vlassara, Helen
    Striker, Gary E.
    Zheng, Feng
    LABORATORY INVESTIGATION, 2011, 91 (10) : 1459 - 1471
  • [47] Hypercholesterolemia Induced Immune Response and Inflammation on Progression of Atherosclerosis in Apob tm2Sgy Ldlr tm1Her/J Mice
    Rao, Lakshmi Narasimha
    Ponnusamy, Thiruvelselvan
    Philip, Sheena
    Mukhopadhyay, Rupak
    Kakkar, Vijay V.
    Mundkur, Lakshmi
    LIPIDS, 2015, 50 (08) : 785 - 797
  • [48] The receptor tyrosine kinase Ron attenuates obesity-induced atherosclerosis progression and liver injury by down-regulating inflammation in ApoE-/- mice
    Yu, Shan
    Xia, Mingcan
    Xiong, Na
    Hankey, Pamela
    JOURNAL OF IMMUNOLOGY, 2012, 188
  • [49] Silencing hepatic PCSK9 via novel chimeric AAV8 mitigates the progression of atherosclerosis by inhibiting inflammation in ApoE-/- mice
    Chen, Xiaocui
    Sun, Minghui
    Ma, Xiang
    Ma, Yitong
    Chen, Bangdang
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2025, 33 (01)
  • [50] Slfn4 deficiency improves MAPK-mediated inflammation, oxidative stress, apoptosis and abates atherosclerosis progression in apolipoprotein E-deficient mice
    Zheng, Qianqian
    Duan, Liangwei
    Lou, Yunwei
    Chao, Tianzhu
    Guo, Guo
    Lu, Liaoxun
    Zhang, Hongxia
    Zhao, Yucong
    Liang, Yinming
    Wang, Hui
    ATHEROSCLEROSIS, 2021, 337 : 42 - 52